TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT07897760: Evaluating the Effects of the EXOPULSE Suit on Mobility, Walking Ability, and Balance in People With Multiple Sclerosis

Sponsor: Otto Bock Healthcare Products GmbH · Phase: PHASE2 · Area: CNS_NEUROLOGY · Target Enrollment: 100 pts

Competing Trials Overlap

4 Active Trials

Excess Burn Exposure

$12,416,000

Rescue Site Savings

+$8,186,800

Unlock Full NCT07897760 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07897760 Rescue Dossier →